Phase 4 Tuberculosis Trial, Recruiting (NCT07477119)

Phase 4 Tuberculosis Trial, Recruiting NCT07477119 Sponsor: Marco Schiuma Condition: Tuberculosis

Printed from Voxsanity (voxsanity.com.au) — NCT07477119 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Tuberculosis

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You have been diagnosed with a type of tuberculosis (TB) that is resistant to multiple standard antibiotics (known as MDR-TB).
Your doctor has prescribed a specific combination of medicines that includes a drug called linezolid (as part of a treatment plan called BPaL or BPaL-M).
You are 15 years old or older.
You (or your parent or legal guardian if you are under 18) have agreed to take part and signed a consent form.

Who may not be able to join:

You are currently pregnant or breastfeeding.
You have severe liver or kidney problems.
You have had a known allergic reaction or serious sensitivity to linezolid in the past.
You are currently taking other medicines that could interact badly with linezolid (confirm with trial site).

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 27 July 2026

Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.

Contact this trial

Principal Investigator: Marco Schiuma, ASST Fatebenefratelli Sacco, Luigi Sacco University Hospital, Milan, Italy

Phone: +393284931986

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07477119

Sponsor: Marco Schiuma

Phase: Phase 4

Status: Recruiting

Condition: Tuberculosis

Trial contact: +393284931986

More information: https://clinicaltrials.gov/study/NCT07477119

Eligibility summary (AI generated)

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You have been diagnosed with a type of tuberculosis (TB) that is resistant to multiple standard antibiotics (known as MDR-TB).
Your doctor has prescribed a specific combination of medicines that includes a drug called linezolid (as part of a treatment plan called BPaL or BPaL-M).
You are 15 years old or older.
You (or your parent or legal guardian if you are under 18) have agreed to take part and signed a consent form.

Who may not be able to join:

You are currently pregnant or breastfeeding.
You have severe liver or kidney problems.
You have had a known allergic reaction or serious sensitivity to linezolid in the past.
You are currently taking other medicines that could interact badly with linezolid (confirm with trial site).

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 27 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Phase 4

Sponsor

Marco Schiuma

Registry

ClinicalTrials.gov

Start date

1 April 2026

Est. completion

1 October 2027

Where this trial is recruiting

Guinea

Primary endpoints

Rate of linezolid related side effects.

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov